Analyst Price Targets — VERU
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 3, 2024 11:38 am | Yi Chen | H.C. Wainwright | $3.00 | $1.67 | TheFly | Veru price target raised to $3 from $2 at H.C. Wainwright |
| April 15, 2024 5:50 am | Leland Gershell | Oppenheimer | $5.00 | $1.52 | StreetInsider | Veru, Inc. (VERU) PT Lowered to $5 at Oppenheimer |
| December 7, 2022 6:28 am | — | H.C. Wainwright | $18.00 | $5.66 | Benzinga | HC Wainwright & Co. Maintains Buy on Veru, Lowers Price Target to $18 |
| April 15, 2022 11:26 am | Leland Gershell | Oppenheimer | $36.00 | $14.95 | Pulse 2.0 | Veru (VERU) Stock: $36 Price Target And Outperform Rating |
Latest News for VERU
Veru Inc. (NASDAQ: VERU - Get Free Report) shares passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $2.69 and traded as low as $2.39. Veru shares last traded at $2.43, with a volume of 18,400 shares traded. Wall Street Analysts Forecast Growth Several research firms
Veru Inc. (NASDAQ: VERU - Get Free Report)'s stock price passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $2.81 and traded as low as $2.19. Veru shares last traded at $2.23, with a volume of 47,526 shares traded. Wall Street Analyst Weigh In VERU has
-- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients with obesity receiving semaglutide -- -- Interim analysis expected in the first quarter calendar year 2027-- -- Final topline clinical data expected in the fourth quarter calendar year 2027--
Veru Inc. (VERU) Q1 2026 Earnings Call Transcript
Veru (NASDAQ: VERU - Get Free Report) and Flora Growth (NASDAQ: FLGC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership. Earnings and Valuation This table compares Veru and
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VERU.
U.S. House Trading
No House trades found for VERU.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.